Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

Multiple Endocrine Neoplasia

Pamela L. Kunzmonoclonal_antibodyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Multiple Endocrine Neoplasia cohort.

Asset / SponsorPhaseRating
Oxodotreotide
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2B
Octreotide Pamoate
Federico II University
Phase 2B
FDOPA
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2B

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:

breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →
inflammatory breast carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
HER2 positive breast carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →